STRIDES PHARMA SCIENCE
Back to Balance Sheet
|
STRIDES PHARMA SCIENCE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹602 Cr | ₹621 Cr | ₹1,210 Cr | ₹966 Cr | ₹1,264 Cr |
What is the latest Total Non-Current Liabilities ratio of STRIDES PHARMA SCIENCE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹602 Cr |
Mar2024 | ₹621 Cr |
Mar2023 | ₹1,210 Cr |
Mar2022 | ₹966 Cr |
Mar2021 | ₹1,264 Cr |
How is Total Non-Current Liabilities of STRIDES PHARMA SCIENCE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹602 Cr | -3.19 | |
Mar2024 | ₹621 Cr | -48.65 | |
Mar2023 | ₹1,210 Cr | 25.33 | |
Mar2022 | ₹966 Cr | -23.63 | |
Mar2021 | ₹1,264 Cr | - |
Compare Total Non-Current Liabilities of peers of STRIDES PHARMA SCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
STRIDES PHARMA SCIENCE | ₹8,371.3 Cr | 2.1% | 2.5% | -8.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
STRIDES PHARMA SCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
STRIDES PHARMA SCIENCE | 2.1% |
2.5% |
-8.3% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses